Siegfried, a Swiss leader taking innovations to industrial scale for the pharmaceutical industry
Siegfried’s success in Evionnaz is largely attributed to the expertise and flexibility of its workforce.
Debiopharm invests CHF 30 million in Valais amidst workforce surge
Debiopharm Research & Manufacturing has announced an investment of over CHF 30 million in a Martigny lab expansion as staff numbers rise from 150 to 200 in a year.
Valsynthèse, 40 years of innovation in the canton of Valais
Valsynthèse, the ‘fine chemistry’ business unit of the Société Suisse des Explosifs, celebrates four decades of steering innovative chemical solutions in Valais.
BioArk’s third building in Monthey has just been inaugurated and is already almost full!
The Monthey-based technology site, which celebrates its 20th anniversary this year, inaugurated its third building on Friday.
AlphaOnco Swiss settles in Monthey!
AlphaOnco Swiss has opened its new office in Valais.
Swiss Biotech Center: innovative solutions for biopharmaceutical development
Swiss Biotech Center is a leading research and development center in the field of biotechnology.
Bachem signs a CHF 1 billion peptide supply contract!
Bachem announced the signing of a new work mandate for the delivery of large volumes of peptides for a minimum total of CHF 1 billion.
Retinal diseases: Kodiak Sciences inaugurates its facility in Visp
Kodiak Sciences has just launched its new production facility for drugs to treat retinal diseases.